About this item:

165 Views | 139 Downloads

Author Notes:

Dr Jesús Rivera-Nieves, Inflammatory Bowel Disease Center, Division of Gastroenterology, 9500 Gilman Drive Bldg UC303, San Diego, CA 92093-0063, USA; jriveran@ucsd.edu

All authors contributed to data generation, data analysis and interpretation as well as writing of the manuscript.

The authors thank Matthew D P Lebsack and Erin Walsh for technical assistance.

Anti-mouse CCR7 was a gift from Dr Fergus Byrne (Amgen, Thousand Oaks, California, USA); and anti-TNF from Dr David Shealy (Centocor, Malvern, Pennsylvania, USA).

Authors declare no competing interests.

Subjects:

Research Funding:

This work was supported by National Institutes of Health (USPHS DK080212); and Crohn’s and Colitis Foundation of America Grants (CCFA # 2826) to JR-N; NIH/NCRR Colorado CTSI: UL1 RR025780; and Crohn’s and Colitis Foundation of America Grants (CCFA # 3332) to ENM.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Gastroenterology & Hepatology
  • NAIVE T-LYMPHOCYTES
  • CROHNS-DISEASE
  • RECEPTOR CCR7
  • PERIPHERAL-TISSUES
  • EXPRESSION
  • MODEL
  • INFLAMMATION
  • NEOGENESIS
  • CCL21
  • CHEMOTAXIS

Ectopic lymphoid tissue alters the chemokine gradient, increases lymphocyte retention and exacerbates murine ileitis

Journal Title:

Gut

Volume:

Volume 62, Number 1

Publisher:

, Pages 53-62

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Background: The earliest endoscopically-evident lesion in Crohn's disease is the aphthous ulcer, which develops over ectopic lymphoid tissues (ie, inducible lymphoid follicles (ILF), tertiary lymphoid tissue (TLT)) in the chronically inflamed intestine. ILF/TLT are induced within effector sites by homeostatic lymphoid chemokines, but their role in the development of intestinal ILF/TLT and in the pathogenesis of Crohn's disease is poorly understood. Design: Using a mouse model of Crohn's-like ileitis (TNFΔARE) which develops florid induction of ILF/TLT within its terminal ileum, the contribution of the CCR7/ CCL19/CCL21 chemokine axis during the development of TLT and its role in disease pathogenesis were assessed. Results: Both CCL19 and CCL21 were increased within the inflamed ileum of TNFΔARE mice, which resulted in CCR7 internalisation and impaired T cell chemotaxis. ILF/ TLT were a major source of CCL19 and CCL21 and increased local synthesis, augmented recruitment/ retention of effector, naïve and central memory T cell subsets within the inflamed ileum. Immunoblockade of CCR7 resulted in further effector T cell retention and exacerbation of ileitis. Conclusions: Induction of ILF/TLT in the chronically inflamed intestine alters the homeostatic CCL19-CCL21 lymphoid-chemokine gradient and increases recruitment/ retention of effector CCR7+ T cell subsets within the terminal ileum, contributing to the perpetuation of chronic inflammation. Thus, blockade of CCR7 or its ligands might result in deleterious consequences for subjects with chronic inflammatory diseases.

Copyright information:

© 2019 BMJ Publishing Group Ltd & British Society of Gastroenterology. All rights reserved.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote